As GSK's vaccine ambitions grow with the launch of new respiratory syncytial virus (RSV) shot Arexvy, the company is once again investing to support its manufacturing operations. The British pharma is ...
GlaxoSmithKline recently closed out a voluntary recall of 130,500 doses of its market-leading shingles vaccine Shingrix after finding cracks in two vials. In a recall notice posted on FDA’s website, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback